Many AI founders now find it necessary to raise at valuations requiring absolute domination of the field; Brex, once valued at $12B, shows the downsides of this
Capital One just announced it's acquiring Brex for $5.15 billion. An incredible, top .1% “exit” in less than 10 years …
SaaStrJason Lemkin
Context & Ripple Effects
Brex’s sale to Capital One for $5.15 billion turns a formerly $12 billion private valuation into a concrete liquidity benchmark. It matters because a high-profile outcome can be successful for the company while still falling well short of the price implied by an earlier funding round.
Capital One acquires Brex, while Brex’s prior $12 billion valuation is effectively superseded by a $5.15 billion transaction value.
Brex investors and other stakeholders face an outcome below the company’s earlier private-market benchmark, despite the acquisition being a substantial exit.
Second-order effects
Founders raising at aggressive valuations face a narrower set of credible future outcomes: they must support the next round or exit with performance that justifies the higher starting point.
Investors may place more weight on exit comparables and financing durability when evaluating AI companies, especially as back-to-back or multitiered fundraising raises questions about valuation quality.
Third-order effects
If elevated private valuations continue to outrun realizable acquisition or public-market values, capital will increasingly favor companies able to sustain repeated financing and demonstrate category leadership.
The pattern points toward greater concentration in frontier AI: only firms with enough capital endurance to meet inflated expectations may retain strategic independence, while others become acquisition candidates.
The trend: AI’s funding boom is raising the premium on capital endurance, as private valuations increasingly require companies to deliver unusually dominant outcomes to validate them.
HUBRISTIC FUNDRAISING “Brex raised $300 million at a $12.3 billion valuation in October 2022—technically 2022, but really the tail end of the 2021 madness before rates spiked and everything crashed. At that valuation, with maybe $200-250M in revenue at the time, Brex was being [i…
Thoughtful piece... but for most VCs the incentives encourage hubristic fundraising. This isn't really a founder problem... it's a VC problem. Also a few ‘modern day AI’ hubristic comps do not deserve to be in the list 👀
@jasonlk I think this is very smart / very much on-point. It can be very dangerous not to play the game on the field though - if your competitors are doing this and you are not, it can be very hard to survive.
Fantastic and balanced piece. It's less about right vs wrong and more about understanding tradeoffs and the rules of the game. It's always a lot more nuance than the average, simplistic twitter/hn take. PS: If you ever get the chance, take Jason's check.
Epic post by @jasonlk Know the trade off If you roll the dice and stumble you won't capture all the upside But obviously still an epic outcome for founders, early employees and early investors With AI companies unlike with Brex unit economics will be another big variable.
I've been in the startup game for a minute, there is a very wide delta between private market valuation & public valuations , especially at this moment. Worth a read if you are a founder who is raising.
My only qualm with this article is the claim that, say, Loveable is “worth” more than Brex. Brex sold for $5.15B. Loveable is “worth” $6.6B. If early-stage valuations are hype; late-stage valuations are fake.